These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 15564882)

  • 21. The eighth and ninth transmembrane domains in organic anion transporting polypeptide 1B1 affect the transport kinetics of estrone-3-sulfate and estradiol-17beta-D-glucuronide.
    Miyagawa M; Maeda K; Aoyama A; Sugiyama Y
    J Pharmacol Exp Ther; 2009 May; 329(2):551-7. PubMed ID: 19244099
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Substrate-dependent inhibition of organic anion transporting polypeptide 1B1: comparative analysis with prototypical probe substrates estradiol-17β-glucuronide, estrone-3-sulfate, and sulfobromophthalein.
    Izumi S; Nozaki Y; Komori T; Maeda K; Takenaka O; Kusano K; Yoshimura T; Kusuhara H; Sugiyama Y
    Drug Metab Dispos; 2013 Oct; 41(10):1859-66. PubMed ID: 23920221
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment with proteasome inhibitor bortezomib decreases organic anion transporting polypeptide (OATP) 1B3-mediated transport in a substrate-dependent manner.
    Alam K; Farasyn T; Crowe A; Ding K; Yue W
    PLoS One; 2017; 12(11):e0186924. PubMed ID: 29107984
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of the hepatic efflux transporters of organic anions using double-transfected Madin-Darby canine kidney II cells expressing human organic anion-transporting polypeptide 1B1 (OATP1B1)/multidrug resistance-associated protein 2, OATP1B1/multidrug resistance 1, and OATP1B1/breast cancer resistance protein.
    Matsushima S; Maeda K; Kondo C; Hirano M; Sasaki M; Suzuki H; Sugiyama Y
    J Pharmacol Exp Ther; 2005 Sep; 314(3):1059-67. PubMed ID: 15901800
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rifampicin Transport by OATP1B1 Variants.
    Litjens CHC; van den Heuvel JJMW; Russel FGM; Aarnoutse RE; Te Brake LHM; Koenderink JB
    Antimicrob Agents Chemother; 2020 Sep; 64(10):. PubMed ID: 32690641
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Organic anion transporter 1B1: an important factor in hepatic thyroid hormone and estrogen transport and metabolism.
    van der Deure WM; Friesema EC; de Jong FJ; de Rijke YB; de Jong FH; Uitterlinden AG; Breteler MM; Peeters RP; Visser TJ
    Endocrinology; 2008 Sep; 149(9):4695-701. PubMed ID: 18499754
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Functional Consequences of Pravastatin Isomerization on OATP1B1-Mediated Transport.
    Wagner JB; Ruggiero M; Leeder JS; Hagenbuch B
    Drug Metab Dispos; 2020 Nov; 48(11):1192-1198. PubMed ID: 32892153
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analysis of amino acid residues in the predicted transmembrane pore influencing transport kinetics of the hepatic drug transporter organic anion transporting polypeptide 1B1 (OATP1B1).
    Gruetz M; Sticht H; Glaeser H; Fromm MF; König J
    Biochim Biophys Acta; 2016 Nov; 1858(11):2894-2902. PubMed ID: 27594653
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Functional analysis of a mutation in the SLCO1B1 gene (c.1628T>G) identified in a Japanese patient with pravastatin-induced myopathy.
    Furihata T; Satoh N; Ohishi T; Ugajin M; Kameyama Y; Morimoto K; Matsumoto S; Yamashita K; Kobayashi K; Chiba K
    Pharmacogenomics J; 2009 Jun; 9(3):185-93. PubMed ID: 19238167
    [TBL] [Abstract][Full Text] [Related]  

  • 30. SLCO1B1 polymorphism and oral antidiabetic drugs.
    Kalliokoski A; Neuvonen PJ; Niemi M
    Basic Clin Pharmacol Toxicol; 2010 Oct; 107(4):775-81. PubMed ID: 20406215
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Influence of non-steroidal anti-inflammatory drugs on organic anion transporting polypeptide (OATP) 1B1- and OATP1B3-mediated drug transport.
    Kindla J; Müller F; Mieth M; Fromm MF; König J
    Drug Metab Dispos; 2011 Jun; 39(6):1047-53. PubMed ID: 21389119
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Organic Anion Transporter Polypeptide 1B1 Polymorphism Modulates the Extent of Drug-Drug Interaction and Associated Biomarker Levels in Healthy Volunteers.
    Yee SW; Giacomini MM; Shen H; Humphreys WG; Horng H; Brian W; Lai Y; Kroetz DL; Giacomini KM
    Clin Transl Sci; 2019 Jul; 12(4):388-399. PubMed ID: 30982223
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Methotrexate pharmacokinetics in transgenic mice with liver-specific expression of human organic anion-transporting polypeptide 1B1 (SLCO1B1).
    van de Steeg E; van der Kruijssen CM; Wagenaar E; Burggraaff JE; Mesman E; Kenworthy KE; Schinkel AH
    Drug Metab Dispos; 2009 Feb; 37(2):277-81. PubMed ID: 19022939
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multiple human isoforms of drug transporters contribute to the hepatic and renal transport of olmesartan, a selective antagonist of the angiotensin II AT1-receptor.
    Yamada A; Maeda K; Kamiyama E; Sugiyama D; Kondo T; Shiroyanagi Y; Nakazawa H; Okano T; Adachi M; Schuetz JD; Adachi Y; Hu Z; Kusuhara H; Sugiyama Y
    Drug Metab Dispos; 2007 Dec; 35(12):2166-76. PubMed ID: 17823233
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Investigation of Fluorescein Derivatives as Substrates of Organic Anion Transporting Polypeptide (OATP) 1B1 To Develop Sensitive Fluorescence-Based OATP1B1 Inhibition Assays.
    Izumi S; Nozaki Y; Komori T; Takenaka O; Maeda K; Kusuhara H; Sugiyama Y
    Mol Pharm; 2016 Feb; 13(2):438-48. PubMed ID: 26696140
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preclinical Mouse Models To Study Human OATP1B1- and OATP1B3-Mediated Drug-Drug Interactions in Vivo.
    Durmus S; Lozano-Mena G; van Esch A; Wagenaar E; van Tellingen O; Schinkel AH
    Mol Pharm; 2015 Dec; 12(12):4259-69. PubMed ID: 26474710
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of organic anion-transporting polypeptide 1B1 (OATP1B1) polymorphism on the single- and multiple-dose pharmacokinetics of enalapril in healthy Chinese adult men.
    Tian L; Liu H; Xie S; Jiang J; Han L; Huang Y; Li Y
    Clin Ther; 2011 May; 33(5):655-63. PubMed ID: 21665049
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Functional Characterization of Six
    Häkkinen K; Kiander W; Kidron H; Lähteenvuo M; Urpa L; Lintunen J; Vellonen KS; Auriola S; Holm M; Lahdensuo K; Kampman O; Isometsä E; Kieseppä T; Lönnqvist J; Suvisaari J; Hietala J; Tiihonen J; Palotie A; Ahola-Olli AV; Niemi M
    Mol Pharm; 2023 Mar; 20(3):1500-1508. PubMed ID: 36779498
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Effect of Single Nucleotide Variations in the Transmembrane Domain of OATP1B1 on in vitro Functionality.
    Kiander W; Vellonen KS; Malinen MM; Gynther M; Hagström M; Bhattacharya M; Auriola S; Koenderink JB; Kidron H
    Pharm Res; 2021 Oct; 38(10):1663-1675. PubMed ID: 34647232
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of fibrates on human organic anion-transporting polypeptide 1B1-, multidrug resistance protein 2- and P-glycoprotein-mediated transport.
    Yamazaki M; Li B; Louie SW; Pudvah NT; Stocco R; Wong W; Abramovitz M; Demartis A; Laufer R; Hochman JH; Prueksaritanont T; Lin JH
    Xenobiotica; 2005 Jul; 35(7):737-53. PubMed ID: 16316932
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.